![]() ![]() Illumina acquired Epicentre Biotechnologies, based in Madison, Wisconsin, on January 11, 2011. This was part of the company's strategy at the time to open its own CLIA lab and begin offering clinical genetic testing itself. Until 2010, Illumina sold only instruments that were labeled "for research use only" in early 2010, Illumina obtained FDA approval for its BeadXpress system to be used in clinical tests. As of May 2011, Illumina reduced the price to $4,000. In June 2009, Illumina announced the launch of their own Personal Full Genome Sequencing Service at a depth of 30X for $48,000 per genome, and a year later dropped the price to $19,500. It is being used to perform a range of analyses, including whole genome resequencing, gene-expression analysis, and small ribonucleic acid (sRNA) analysis. Illumina also uses the DNA colony sequencing technology, invented in 1997 by Pascal Mayer and Laurent Farinelli and which was acquired by Solexa in 2004 from Manteia Predictive Medicine. was formed in 2005 when Solexa Ltd reversed into Lynx Therapeutics of Hayward. Solexa was founded in June 1998 by Shankar Balasubramanian and David Klenerman to develop and commercialize genome-sequencing technology invented by the founders at the University of Cambridge. On January 26, 2007, the company completed the acquisition of the British company Solexa, Inc. Illumina's technologies are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe. Illumina currently offers microarray-based products and services for an expanding range of genetic analysis sequencing, including SNP genotyping, gene expression, and protein analysis. Illumina began offering single nucleotide polymorphism (SNP) genotyping services in 2001 and launched its first system, the Illumina BeadLab, in 2002, using GoldenGate Genotyping technology. Illumina completed its initial public offering in July 2000. In 1999, Illumina acquired Spyder Instruments (founded by Michal Lebl, Richard Houghten, and Jutta Eichler) for their technology of high-throughput synthesis. While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee. Czarnik, Stuelpnagel, and Chee at their Illumina office in the summer of 1998
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |